ZIM LABORATORIES LIMITED
ZIMLAB · General/Diversified · NSE
₹83
Current Market Price
Fair Value (DCF)
₹23
Margin of Safety
-71.8%
Updated 22h ago
YieldIQ Score
38/100
Piotroski F-Score
4/9
Economic Moat
Narrow
Confidence
38%
ROE
—
Debt/Equity
0.49
WACC
11.1%
Market Cap
₹443 Cr
Quality & Valuation
Neutral model outputs — no recommendations.
ROCE
9.0%
Return on capital employed
EV / EBITDA
15.4×
Enterprise multiple
Debt / EBITDA
3.4×
Leverage vs earnings
Interest Coverage
2.9×
EBIT covers interest
Current Ratio
1.39×
Short-term liquidity
Asset Turnover
0.77×
Revenue per ₹ of assets
Revenue CAGR (3Y)
3.4%
3-year revenue growth
Revenue CAGR (5Y)
—
5-year revenue growth
DCF Scenario Analysis
vs CMP ₹82.68
Bear case
₹9.95
MoS -731.0%
Base case
₹23.32
MoS -254.5%
Bull case
₹35.78
MoS -131.1%
Ratio Trends
ZIMLAB · last 4 annual periods
ROE
4.8%
ROCE
12.9%
Operating Margin
—
Debt / Equity
0.47×
PE
15.8×
EV / EBITDA
7.6×
Historical Financials
ZIMLAB · Annual, last 4 years· amounts in ₹Cr unless noted
| Metric | 2022 | 2023 | 2024 | 2025 | CAGR |
|---|---|---|---|---|---|
| Revenue | ₹328 Cr | ₹389 Cr | ₹356 Cr | ₹363 Cr | +3.4% |
| EBITDA | ₹44.2 Cr | ₹57.8 Cr | ₹45.5 Cr | ₹47.6 Cr | +2.5% |
| EBIT | — | ₹11.2 Cr | ₹13.1 Cr | — | +5.3% |
| PAT | ₹14.6 Cr | ₹24.4 Cr | ₹17.3 Cr | ₹12.2 Cr | -5.8% |
| EPS (diluted) | — | ₹1.48 | ₹1.62 | — | +3.1% |
| CFO | ₹49.2 Cr | ₹37.5 Cr | ₹11.5 Cr | ₹41.2 Cr | -5.8% |
| CapEx | ₹-15.2 Cr | — | — | ₹-40.8 Cr | — |
| FCF | ₹34.0 Cr | — | — | ₹0.4 Cr | -78.1% |
| Total Assets | ₹342 Cr | ₹342 Cr | ₹443 Cr | ₹472 Cr | +11.4% |
| Total Debt | ₹53.3 Cr | ₹34.9 Cr | ₹70.8 Cr | ₹118 Cr | +30.2% |
| Shareholders' Equity | ₹176 Cr | ₹200 Cr | ₹232 Cr | ₹252 Cr | +12.8% |
CAGR computed across the visible window. Signs reverse if start value is zero or negative.
Peer Comparison
ZIMLAB vs 5 closest peers by market-cap band
| Peer | MoS | Score | Verdict | ROE | PE |
|---|---|---|---|---|---|
| ALBERTDAVD ALBERTDAVD | — | — | Pending | 4.4% | — |
| KILITCH KILITCH | — | — | Pending | 13.3% | — |
| VALIANTLAB VALIANTLAB | — | — | Pending | -0.9% | — |
| AMANTA AMANTA | — | — | Pending | 10.9% | — |
| MEDICAMEQ MEDICAMEQ | — | — | Pending | 3.3% | — |
Click a ticker to view its fair-value analysis.
Dividend History
No dividend events recorded for ZIMLAB in the last 10 years.
AI Analysis Summary
Model-generated description of metrics. Not investment advice. ZIM LABORATORIES LIMITED (ZIMLAB.NS) trades at 82.68 vs a model fair value of 23.32, a gap of -71.8%. Piotroski F-score: 4/9. Moat label:...
Read full AI analysis →Reverse DCF
Market-implied growth
What FCF growth is priced in →
Risk Analysis
Volatility & drawdown
Risk profile of ZIMLAB →
DuPont
ROE decomposition
Why ROE is what it is →
Technicals
RSI, MACD, MAs
Reference indicators →
News & Filings
Recent activity
BSE filings + news for ZIMLAB →
Compare
Head-to-head with peers
Compare ZIMLAB side by side →
Run Full Interactive Analysis
Interactive DCF sliders, sensitivity heatmap, peer comparison, and more.
Analyse ZIMLABNow →Model estimates using publicly available data. Not investment advice. YieldIQ is not registered with SEBI as an investment adviser or research analyst. Past performance does not guarantee future results.